Vijay Kotte - Apr 10, 2023 Form 4 Insider Report for GoHealth, Inc. (GOCO)

Role: Chief Executive Officer, Director
Signature: /s/ Brian Farley, Attorney-in-fact
Stock symbol: GOCO
Transactions as of: Apr 10, 2023
Transactions value $: $0
Form type: 4
Date filed: 4/12/2023, 04:27 PM
Previous filing: Jun 8, 2022
Next filing: May 17, 2023

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	GOCO	Class A Common Stock	Award	$0	+167K	+35.29%	$0.00	639K	Apr 10, 2023	Direct	F1, F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	GOCO	Stock Option	Award	$0	+83.3K		$0.00	83.3K	Apr 10, 2023	Class A Common Stock	83.3K	$14.10	Direct	F3

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Represents a grant of restricted stock units which vests in three annual installments, with the first such annual installment vesting on April 10, 2024.
F2	Reflects the amount of shares beneficially held following a 1-for-15 reverse stock split effected by the Issuer on November 17, 2022, which was exempt from reporting pursuant to Rule 16a-19.
F3	The stock option vests in three equal annual installments beginning on April 10, 2024.